MedTrace Logo

Clinical Decision Support System for Quality Assurance in Potassium-Increasing Drug-Drug-Interactions

NCT02020317 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3341

Last updated 2015-06-08

No results posted yet for this study

Summary

To investigate the impact of reminders for serum potassium monitoring and of hyperkalemia alerts during potassium-increasing drug-drug-interactions.

Conditions

  • Hyperkalemia

Interventions

BEHAVIORAL

decision support in potassium-inc. drug-drug-interactions

display of computer-based reminders for serum potassium monitoring and hyperkalemia alerts

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Juerg Blaser, PhD, Prof · University Hospital Zurich, Center for Clinical Research, Research Center for Medical Informatics

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02020317 on ClinicalTrials.gov